2005Zhonghua weishengwuxue he mianyixue zazhiRequires access

Inhibitory effects of vector-based siRNA targeting S gene on hepatitis B virus gene expression in HepG2 2.2.15 cells

Jiayun Liu, Long-yang Ma, Qingxia Li, Huang Hongyan, Wen Weihong, Jia Lintao, Caifang Xue, Yinghui Li, Chengji Wang, Angang Yang

Open publisher page 0 citations

Abstract

Objective To construct pSUPER vectors expressing short interfering RNA(siRNA) targeting HBV S gene sequence and to evaluate inhibitory effect of these siRNA on HBV replication in HepG2 2.2.15 cells. Methods Based on the sequence of HBV in HepG2 2.2.15 cells, two sequences of targeting HBV S gene were cloned into a RNA polymerase Ⅲ based expression vector pSUPER. The recombinant plasmids were cotransfected with pTK-Hyg into HepG2 2.2.15 cells and monoclonal cell strains were screened. HBsAg and HBeAg in the supernatant of the screened cell strains were assayed with Abbott MEIA kits, the expression of intracellular viral antigens was determined by immunofluorescence staining and HBV mRNA were detected by RT-PCR. Results The pSUPER-S1 and pSUPER-S2 siRNA expression vectors were successfully constructed. The siRNA effectively inhibited the secretion of surface antigen and e antigen of HBV in HepG2 2.2.15 cells by 83% and 78% respectively. Immunofluorescence staining showed that intracellular viral antigens were significantly reduced. RT-PCR results showed that the HBV mRNA was markedly decreased. Whereas the irrelevant siRNA expression vector and control did not show any inhibitory effect on the replication and expression of HBV. Conclusion These results demonstrate that vector-based siRNA targeting HBV S gene can consistently inhibit HBV replication with great potency and specificity in vitro.

About this research paper

What this paper is about

Objective To construct pSUPER vectors expressing short interfering RNA(siRNA) targeting HBV S gene sequence and to evaluate inhibitory effect of these siRNA on HBV replication in HepG2 2.2.15 cells. Methods Based on the sequence of HBV in HepG2 2.2.15 cells, two sequences of targeting HBV S gene were cloned into a RNA polymerase Ⅲ based expression vector pSUPER. The recombinant plasmids were cotransfected with pTK-Hyg into HepG2 2.2.15 cells and monoclonal cell strains were screened. HBsAg and HBeAg in the supernatant of the screened cell strains were assayed with Abbott MEIA kits, the expression of intracellular viral antigens was determined by immunofluorescence staining and HBV mRNA were detected by RT-PCR. Results The pSUPER-S1 and pSUPER-S2 siRNA expression vectors were successfully constructed. The siRNA effectively inhibited the secretion of surface antigen and e antigen of HBV in HepG2 2.2.15 cells by 83% and 78% respectively. Immunofluorescence staining showed that intracellular viral antigens were significantly reduced. RT-PCR results showed that the HBV mRNA was markedly decreased. Whereas the irrelevant siRNA expression vector and control did not show any inhibitory effect on the replication and expression of HBV. Conclusion These results demonstrate that vector-based siRNA targeting HBV S gene can consistently inhibit HBV replication with great potency and specificity in vitro.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To construct pSUPER vectors expressing short interfering RNA(siRNA) targeting HBV S gene sequence and to evaluate inhibitory effect of these siRNA on HBV replication in HepG2 2.2.15 cells. Methods Based on the sequence of HBV in HepG2 2.2.15 cells, two sequences of targeting HBV S gene were cloned into a RNA polymerase Ⅲ based expression vector pSUPER. The recombinant plasmids were cotransfected with pTK-Hyg into HepG2 2.2.15 cells and monoclonal cell strains were screened. HBsAg and HBeAg in the supernatant of the screened cell strains were assayed with Abbott MEIA kits, the expression of intracellular viral antigens was determined by immunofluorescence staining and HBV mRNA were detected by RT-PCR. Results The pSUPER-S1 and pSUPER-S2 siRNA expression vectors were successfully constructed. The siRNA effectively inhibited the secretion of surface antigen and e antigen of HBV in HepG2 2.2.15 cells by 83% and 78% respectively. Immunofluorescence staining showed that intracellular viral antigens were significantly reduced. RT-PCR results showed that the HBV mRNA was markedly decreased. Whereas the irrelevant siRNA expression vector and control did not show any inhibitory effect on the replication and expression of HBV. Conclusion These results demonstrate that vector-based siRNA targeting HBV S gene can consistently inhibit HBV replication with great potency and specificity in vitro.

Key concepts: HBsAg, Molecular biology, Transfection, Hepatitis B virus, HBeAg, Small interfering RNA, Biology, Virology

Related papers

Back to paper searchBrowse research topicsOriginal source
Inhibitory effects of vector-based siRNA targeting S gene on hepatitis B virus gene expression in HepG2 2.2.15 cells — Research Paper | ScholarLens